DE602004026071D1 - Aminopyrone und ihre verwendung als atm inhibitoren - Google Patents
Aminopyrone und ihre verwendung als atm inhibitorenInfo
- Publication number
- DE602004026071D1 DE602004026071D1 DE602004026071T DE602004026071T DE602004026071D1 DE 602004026071 D1 DE602004026071 D1 DE 602004026071D1 DE 602004026071 T DE602004026071 T DE 602004026071T DE 602004026071 T DE602004026071 T DE 602004026071T DE 602004026071 D1 DE602004026071 D1 DE 602004026071D1
- Authority
- DE
- Germany
- Prior art keywords
- group
- optionally substituted
- aminopyrone
- atm inhibitors
- prodrugs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49477603P | 2003-08-13 | 2003-08-13 | |
PCT/GB2004/003507 WO2005016919A1 (en) | 2003-08-13 | 2004-08-13 | Aminopyrones and their use as atm inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004026071D1 true DE602004026071D1 (de) | 2010-04-29 |
Family
ID=34193236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004026071T Active DE602004026071D1 (de) | 2003-08-13 | 2004-08-13 | Aminopyrone und ihre verwendung als atm inhibitoren |
Country Status (19)
Country | Link |
---|---|
US (2) | US7429660B2 (de) |
EP (1) | EP1654257B1 (de) |
JP (1) | JP2007501836A (de) |
KR (1) | KR20060066722A (de) |
CN (1) | CN1867566B (de) |
AT (1) | ATE461193T1 (de) |
AU (1) | AU2004265149A1 (de) |
BR (1) | BRPI0413467A (de) |
CA (1) | CA2534300A1 (de) |
DE (1) | DE602004026071D1 (de) |
ES (1) | ES2341342T3 (de) |
GB (1) | GB2420781B (de) |
HK (1) | HK1097273A1 (de) |
MX (1) | MXPA06001599A (de) |
NO (1) | NO20061126L (de) |
NZ (1) | NZ545919A (de) |
TW (1) | TW200524924A (de) |
WO (1) | WO2005016919A1 (de) |
ZA (1) | ZA200601595B (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0119865D0 (en) * | 2001-08-14 | 2001-10-10 | Cancer Res Campaign Tech | DNA-PK inhibitors |
KR20060066722A (ko) * | 2003-08-13 | 2006-06-16 | 쿠도스 파마슈티칼스 리미티드 | 아미노피론 및 atm억제제로서의 이의 용도 |
US20070238731A1 (en) | 2004-09-20 | 2007-10-11 | Kudos Pharmaceuticals Limited | Dna-Pk Inhibitors |
CN101115747A (zh) * | 2005-02-09 | 2008-01-30 | 库多斯药物有限公司 | Atm抑制剂 |
AR054438A1 (es) * | 2005-04-15 | 2007-06-27 | Kudos Pharm Ltd | Inhibidores de adn -pk |
US20070049588A1 (en) * | 2005-08-31 | 2007-03-01 | Kudos Pharmaceuticals Limited | Atm inhibitor |
US8318688B2 (en) | 2005-12-19 | 2012-11-27 | Northwestern University | Compositions and methods for altering RNAi |
US20080279866A1 (en) * | 2006-08-25 | 2008-11-13 | The Brigham And Women's Hospital, Inc. | Induction of immunosuppression by inhibition of ATM |
EP2117575A4 (de) | 2007-01-03 | 2013-06-05 | Burnham Inst Medical Research | Verfahren und zusammensetzungen in verbindung mit gerinnselbindenden verbindungen |
WO2008080398A1 (en) * | 2007-01-05 | 2008-07-10 | Bkg Pharma Aps | Anti - infective agents such as phenothiazine and thioxanthene derivates to treat infectious diseases |
UY31232A1 (es) * | 2007-07-19 | 2009-03-02 | Compuestos derivados de dibenzotifenilamino-cromen-4-onas activas sustituidas y sus isomeros y aplicaciones | |
JP2013515008A (ja) | 2009-12-18 | 2013-05-02 | サンフォード−バーナム メディカル リサーチ インスティテュート | 凝血塊結合化合物に関連する方法および組成物 |
WO2013003112A1 (en) | 2011-06-27 | 2013-01-03 | The Jackson Laboratory | Methods and compositions for treatment of cancer and autoimmune disease |
WO2013043744A2 (en) | 2011-09-21 | 2013-03-28 | Inception 1, Inc. | Tricyclic compounds useful as neurogenic and neuroprotective agents |
EP3042900B1 (de) * | 2013-08-29 | 2020-09-23 | Fujifilm Corporation | Neuartige morpholinderivate oder salz davon |
KR20160049435A (ko) | 2014-10-27 | 2016-05-09 | 삼성전자주식회사 | Atm 저해제를 포함하는 세포의 노화를 감소시키기 위한 조성물 및 그의 용도 |
US11547703B2 (en) | 2017-02-27 | 2023-01-10 | Impact Therapeutics (Shanghai), Inc | Substituted fused heteroaromatic tricyclic compounds as kinase inhibitors and the use thereof |
CN109045042A (zh) * | 2018-09-21 | 2018-12-21 | 上海交通大学医学院附属上海儿童医学中心 | Atm抑制剂在制备抑制急性淋巴细胞性白血病复发的药物中的应用 |
US20200355997A1 (en) * | 2019-05-08 | 2020-11-12 | Facebook Technologies, Llc | Thianthrene derivatized monomers and polymers for volume bragg gratings |
US11718580B2 (en) | 2019-05-08 | 2023-08-08 | Meta Platforms Technologies, Llc | Fluorene derivatized monomers and polymers for volume Bragg gratings |
US11780819B2 (en) | 2019-11-27 | 2023-10-10 | Meta Platforms Technologies, Llc | Aromatic substituted alkane-core monomers and polymers thereof for volume Bragg gratings |
EP4171651A1 (de) | 2020-06-24 | 2023-05-03 | AstraZeneca UK Limited | Kombination aus antikörper-wirkstoff-konjugat und atm-inhibitor |
US11879024B1 (en) | 2020-07-14 | 2024-01-23 | Meta Platforms Technologies, Llc | Soft mold formulations for surface relief grating fabrication with imprinting lithography |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1303724A (de) | 1969-05-14 | 1973-01-17 | ||
JPH0753725B2 (ja) * | 1987-10-08 | 1995-06-07 | 富山化学工業株式会社 | 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤 |
US5284856A (en) * | 1988-10-28 | 1994-02-08 | Hoechst Aktiengesellschaft | Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives |
US5703075A (en) * | 1988-12-21 | 1997-12-30 | Pharmacia & Upjohn Company | Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
HUT58310A (en) | 1988-12-21 | 1992-02-28 | Upjohn Co | Anti-atherosclerotic and anti-thrombotic 1-benzopyran-4-one- and 2-amino-1,3-benzoxazin-4-one derivatives, process for producing them and pharmaceutical compositions containing them |
JPH03215423A (ja) | 1990-01-18 | 1991-09-20 | Kyowa Hakko Kogyo Co Ltd | 血管拡張剤 |
DE69127690T2 (de) | 1990-06-20 | 1998-02-12 | Pharmacia & Upjohn Company Kal | Antiatherosklerotische und antithrombotische 1-benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on-derivate |
ATE128128T1 (de) | 1990-06-29 | 1995-10-15 | Upjohn Co | Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one. |
US5302613A (en) * | 1990-06-29 | 1994-04-12 | The Upjohn Company | Antiatheroscleroic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones |
US5252735A (en) * | 1990-06-29 | 1993-10-12 | The Upjohn Company | Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones |
EP0610519B1 (de) | 1992-09-02 | 1999-12-01 | Kyowa Hakko Kogyo Co., Ltd. | Anti-hiv-medikament |
JP3521145B2 (ja) * | 1993-04-09 | 2004-04-19 | 富山化学工業株式会社 | 免疫調節剤,細胞接着阻害剤および自己免疫疾患の治療・予防剤 |
US5378725A (en) | 1993-07-19 | 1995-01-03 | The Arizona Board Of Regents | Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof |
US5504103A (en) | 1993-08-25 | 1996-04-02 | Eli Lilly And Company | Inhibition of phosphatidylinositol 3-kinase with 17 β-hydroxywortmannin and analogs thereof |
US5441947A (en) | 1993-08-25 | 1995-08-15 | Eli Lilly And Company | Methods of inhibiting vascular restenosis |
US5468773A (en) | 1993-08-25 | 1995-11-21 | Eli Lilly And Company | Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs |
CA2133815A1 (en) | 1993-10-12 | 1995-04-13 | Jeffrey Alan Dodge | Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof |
US6632789B1 (en) | 1994-04-29 | 2003-10-14 | The United States Of America As Represented By The Secretary Of The Navy | Methods for modulating T cell responses by manipulating intracellular signal transduction |
US5480906A (en) | 1994-07-01 | 1996-01-02 | Eli Lilly And Company | Stereochemical Wortmannin derivatives |
GB9521987D0 (en) | 1995-10-26 | 1996-01-03 | Ludwig Inst Cancer Res | Phosphoinositide 3-kinase modulators |
US5733920A (en) * | 1995-10-31 | 1998-03-31 | Mitotix, Inc. | Inhibitors of cyclin dependent kinases |
WO1997018323A2 (en) | 1995-11-16 | 1997-05-22 | Icos Corporation | Cell-cycle checkpoint phosphatidylinositol- (pik-) related kinases, genes coding therefor and methods for assaying and modulating enzymatic activity |
GB2302021A (en) | 1996-10-16 | 1997-01-08 | Lilly Co Eli | Inhibiting bone loss or resorption |
EP0990028A4 (de) | 1997-06-06 | 2000-09-27 | Mayo Foundation For Medical | Screening auf inhibitoren der phosphatidylinositol verwandten kinase |
WO1998056391A1 (en) | 1997-06-13 | 1998-12-17 | President And Fellows Of Harvard College | Methods for treating human cancers |
FR2776291B1 (fr) | 1998-03-18 | 2000-06-16 | Pf Medicament | Nouveaux derives bis-benzamides, leur procede de fabrication, les compositions pharmaceutiques les contenant et leur utilisation comme medicament |
US6387640B1 (en) * | 1999-02-10 | 2002-05-14 | St. Jude Children's Research Hospital | ATM kinase modulation for screening and therapies |
US6348311B1 (en) * | 1999-02-10 | 2002-02-19 | St. Jude Childre's Research Hospital | ATM kinase modulation for screening and therapies |
US6333180B1 (en) * | 1999-12-21 | 2001-12-25 | International Flavors & Fragrances Inc. | Bioprocess for the high-yield production of food flavor-acceptable jasmonic acid and methyl jasmonate |
EP1257537B1 (de) | 2000-01-24 | 2007-05-30 | AstraZeneca AB | Durch einen morpholinrest substituierte therapeutische verbindungen |
CN1245974C (zh) * | 2000-06-28 | 2006-03-22 | 特瓦制药工业有限公司 | 卡维地洛 |
AU2001288432A1 (en) | 2000-09-01 | 2002-03-22 | Icos Corporation | Materials and methods to potentiate cancer treatment |
ES2236481T3 (es) | 2001-01-16 | 2005-07-16 | Glaxo Group Limited | Combinacion farmaceutica que contiene una 4-quinazolinamina y paclitaxel, carboplatino o vinorelbina para el tratamiento de cancer. |
GB0119863D0 (en) * | 2001-08-14 | 2001-10-10 | Cancer Res Campaign Tech | DNA-PK inhibitors |
GB0119865D0 (en) * | 2001-08-14 | 2001-10-10 | Cancer Res Campaign Tech | DNA-PK inhibitors |
AU2002349912A1 (en) | 2001-10-24 | 2003-05-06 | Iconix Pharmaceuticals, Inc. | Modulators of phosphoinositide 3-kinase |
US6894055B2 (en) | 2001-10-24 | 2005-05-17 | Iconix Pharmaceuticals Inc. | Thieno-2′,3′ -5,6pyrimido[3,4-A]-1,2,4-triazole derivatives as modulators of phoshoinositide 3-kinase |
US7049313B2 (en) * | 2002-02-25 | 2006-05-23 | Kudos Pharmaceuticals Ltd. | ATM inhibitors |
AU2003209990B8 (en) | 2002-02-25 | 2008-10-30 | Kudos Pharmaceuticals Ltd | Pyranones useful as ATM inhibitors |
DE60335359D1 (de) | 2002-04-30 | 2011-01-27 | Kudos Pharm Ltd | Phthalazinonderivate |
KR20060066722A (ko) * | 2003-08-13 | 2006-06-16 | 쿠도스 파마슈티칼스 리미티드 | 아미노피론 및 atm억제제로서의 이의 용도 |
US20070238731A1 (en) * | 2004-09-20 | 2007-10-11 | Kudos Pharmaceuticals Limited | Dna-Pk Inhibitors |
CN101115747A (zh) | 2005-02-09 | 2008-01-30 | 库多斯药物有限公司 | Atm抑制剂 |
AR054438A1 (es) * | 2005-04-15 | 2007-06-27 | Kudos Pharm Ltd | Inhibidores de adn -pk |
UY31232A1 (es) * | 2007-07-19 | 2009-03-02 | Compuestos derivados de dibenzotifenilamino-cromen-4-onas activas sustituidas y sus isomeros y aplicaciones |
-
2004
- 2004-08-13 KR KR1020067002998A patent/KR20060066722A/ko not_active Application Discontinuation
- 2004-08-13 EP EP04768070A patent/EP1654257B1/de active Active
- 2004-08-13 AT AT04768070T patent/ATE461193T1/de not_active IP Right Cessation
- 2004-08-13 CN CN2004800299408A patent/CN1867566B/zh not_active Expired - Fee Related
- 2004-08-13 GB GB0604321A patent/GB2420781B/en not_active Expired - Fee Related
- 2004-08-13 JP JP2006523057A patent/JP2007501836A/ja active Pending
- 2004-08-13 AU AU2004265149A patent/AU2004265149A1/en not_active Abandoned
- 2004-08-13 WO PCT/GB2004/003507 patent/WO2005016919A1/en active Application Filing
- 2004-08-13 TW TW093124420A patent/TW200524924A/zh unknown
- 2004-08-13 US US10/918,180 patent/US7429660B2/en not_active Expired - Fee Related
- 2004-08-13 ES ES04768070T patent/ES2341342T3/es active Active
- 2004-08-13 BR BRPI0413467-2A patent/BRPI0413467A/pt not_active IP Right Cessation
- 2004-08-13 MX MXPA06001599A patent/MXPA06001599A/es active IP Right Grant
- 2004-08-13 CA CA002534300A patent/CA2534300A1/en not_active Abandoned
- 2004-08-13 DE DE602004026071T patent/DE602004026071D1/de active Active
- 2004-08-13 NZ NZ545919A patent/NZ545919A/en unknown
-
2006
- 2006-02-23 ZA ZA200601595A patent/ZA200601595B/xx unknown
- 2006-03-08 NO NO20061126A patent/NO20061126L/no not_active Application Discontinuation
-
2007
- 2007-05-08 HK HK07104900.4A patent/HK1097273A1/xx not_active IP Right Cessation
-
2008
- 2008-09-19 US US12/233,736 patent/US20090043091A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2004265149A1 (en) | 2005-02-24 |
EP1654257B1 (de) | 2010-03-17 |
GB2420781B (en) | 2008-07-09 |
NZ545919A (en) | 2009-07-31 |
ZA200601595B (en) | 2007-03-28 |
BRPI0413467A (pt) | 2006-10-17 |
US20050054657A1 (en) | 2005-03-10 |
KR20060066722A (ko) | 2006-06-16 |
JP2007501836A (ja) | 2007-02-01 |
HK1097273A1 (en) | 2007-06-22 |
MXPA06001599A (es) | 2006-05-19 |
CN1867566A (zh) | 2006-11-22 |
NO20061126L (no) | 2006-05-09 |
WO2005016919A1 (en) | 2005-02-24 |
US20090043091A1 (en) | 2009-02-12 |
GB2420781A (en) | 2006-06-07 |
ES2341342T3 (es) | 2010-06-18 |
EP1654257A1 (de) | 2006-05-10 |
GB0604321D0 (en) | 2006-04-12 |
TW200524924A (en) | 2005-08-01 |
US7429660B2 (en) | 2008-09-30 |
CN1867566B (zh) | 2010-06-16 |
CA2534300A1 (en) | 2005-02-24 |
ATE461193T1 (de) | 2010-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1097273A1 (en) | Aminopyrones and their use as atm inhibitors | |
HK1069827A1 (en) | Pyranones useful as atm inhibitors. | |
TW200616986A (en) | DNA-pk inhibitors | |
DK1417196T3 (da) | DNA-PK inhibitorer | |
AR067613A1 (es) | Inhibidores de adn-pk, uso y sintesis de los mismos | |
MX2009012380A (es) | Compuestos de heteroarilamida pirimidona. | |
TW200638938A (en) | ATM inhibitors | |
MX2010010471A (es) | Derivado de tetrahidroisoquinolina novedoso. | |
GB0119863D0 (en) | DNA-PK inhibitors | |
DE602006020458D1 (de) | Carbonsäureamidverbindung und deren verwendung | |
CO5580804A2 (es) | Derivados de diazepanes utiles como inhibidores de lfa | |
TH92038B (th) | อนุพันธ์คาร์บอกซาไมด์ที่มีลักษณะเอไมด์ | |
ATE407129T1 (de) | Pentafluoroalkylsulfin-naphthaline und und darauf bezogene modulatoren des östrogenrezeptors | |
TH92038A (th) | อนุพันธ์คาร์บอกซาไมด์ที่มีลักษณะเอไมด์ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |